NASDAQ:IBB iShares Biotechnology ETF (IBB) Price, Holdings, & News $129.47 +0.49 (+0.38%) (As of 06/5/2023 ET) Add Compare Share Share Today's Range$128.56▼$129.8650-Day Range$126.17▼$131.9252-Week Range$104.29▼$138.74Volume1.11 million shsAverage Volume1.53 million shsMarket Capitalization$7.70 billionAssets Under Management$7.57 billionDividend Yield0.28%Net Expense Ratio0.44% ProfileProfileChartDividendInstitutional OwnershipHeadlinesHoldingsOptions ChainSEC FilingsShort InterestSocial MediaProfileChartDividendInstitutional OwnershipHeadlinesHoldingsOptions ChainSEC FilingsShort InterestSocial Media About iShares Biotechnology ETF (NASDAQ:IBB)iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.Read More Receive IBB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address IBB ETF News HeadlinesMay 31, 2023 | marketbeat.comThe How and Why of Investing in Biotech Stocks (IBB)One fascinating sector to invest in is the biotech sector which includes companies involved in the research and development of therapeutics and vaccinesMay 31, 2023 | americanbankingnews.comiShares Biotechnology ETF (NASDAQ:IBB) Sees Significant Decline in Short InterestJune 6, 2023 | Behind the Markets (Ad)[BREAKING] New "Living Missile" to Replace Nuclear MissilesCBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!May 31, 2023 | msn.comUnusual Put Option Trade in BlackRock Institutional Trust Company N.A. - iShares Biotechnology ETF (IBB) Worth $94.70KMay 11, 2023 | forbes.comBest Biotech StocksMay 10, 2023 | finance.yahoo.comBiotech ETFs Pop on M&A ResurgenceApril 24, 2023 | msn.com3 Pharma Stocks That Could See a Surge in Demand in 2023April 14, 2023 | americanbankingnews.comInvestors Buy High Volume of iShares Biotechnology ETF Call Options (NASDAQ:IBB)June 6, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...April 7, 2023 | marketwatch.comTrend Tracker for Ishares Biotechnology Etf $IBBSee More Headlines IBB Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Fund Details IssueriShares Fund NameiShares Biotechnology ETF Tax ClassificationRegulated Investment Company Stock ExchangeNASDAQCurrent SymbolNASDAQ:IBB Inception Date2/5/2001 Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkICE Biotechnology Index (TR) (USD) CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Number of Holdings275 Fund Statistics Assets Under Management$7.57 billion Average Daily Volume$1.49 million Discount/Premium7.57% Administrator, Advisor and Custodian AdministratorJPMorgan Chase Bank, N.A. AdvisorBlackRock Fund Advisors CustodianJPMorgan Chase Bank, N.A. DistributorBlackRock Investments, LLC Transfer AgentJPMorgan Chase Bank, N.A. TrusteeN/A Lead Market MakerLatour Trading Options OptionableOptionable Options Volume1,805 Put Options1,336 Call Options469 Short Interest9,370,000 shs Miscellaneous Outstanding Shares59,500,000Beta0.83 Creation Unit50,000 Creation Fee$614.00 iShares Biotechnology ETF ExpensesTypeIBBHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFsManagement Fee0.44%0.54%0.52%0.45%0.49%Other Expenses0.00%0.41%0.48%0.28%0.51%Total Expense0.44%0.69%0.67%0.54%0.66%Fee Waiver0.00%-0.39%-0.49%-0.21%-0.53%Net Expense0.44%0.60%0.58%0.50%0.55% iShares Biotechnology ETF (IBB) Holdings & ExposureTop 10 IBB HoldingsAmgen(NASDAQ:AMGN)Holding Weight: 8.18%Amgen(NASDAQ:AMGN)Holding Weight: 8.18%Gilead Sciences(NASDAQ:GILD)Holding Weight: 7.97%Gilead Sciences(NASDAQ:GILD)Holding Weight: 7.97%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 7.65%Regeneron Pharmaceuticals(NASDAQ:REGN)Holding Weight: 7.65%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 7.58%Vertex Pharmaceuticals(NASDAQ:VRTX)Holding Weight: 7.58%Moderna(NASDAQ:MRNA)Holding Weight: 4.92%Moderna(NASDAQ:MRNA)Holding Weight: 4.92%IBB Sector ExposureIBB Industry ExposureFull Holdings Details Key ExecutivesGeorge G. C. Parker Ph.D.Independent Chairman of the Board of TrusteesMichael Arthur LathamPresident, TrusteeJack GeeChief Financial Officer, TreasurerGeoffrey D. FlynnChief Operating Officer, Executive Vice PresidentBio & Compensation - Amy SchioldagerExecutive Vice PresidentIra P. ShapiroVice President, Chief Legal OfficerMatt TuckerVice PresidentBio & Compensation - Eilleen M. ClavereSecretaryCecilia H. HerbertIndependent TrusteeCharles A. HurtyIndependent TrusteeMore ExecutivesSimilar ETFsVanEck Biotech ETFNASDAQ:BBHVanEck Pharmaceutical ETFNASDAQ:PPHInvesco S&P SmallCap Health Care ETFNASDAQ:PSCHInvesco DWA Healthcare Momentum ETFNASDAQ:PTHProShares Ultra Nasdaq BiotechnologyNASDAQ:BIBInstitutional OwnershipEP Wealth Advisors LLCBought 66,928 shares on 6/5/2023Ownership: 0.112%Empower Advisory Group LLCBought 1,935 shares on 5/25/2023Ownership: 0.003%Ameriprise Financial Inc.Bought 7,140 shares on 5/22/2023Ownership: 0.282%Arete Wealth Advisors LLCBought 2,073 shares on 5/22/2023Ownership: 0.003%Chelsea Counsel Co.Sold 450 shares on 5/19/2023Ownership: 0.009%View All Institutional Transactions IBB ETF - Frequently Asked Questions How have IBB shares performed in 2023? iShares Biotechnology ETF's stock was trading at $131.29 on January 1st, 2023. Since then, IBB shares have decreased by 1.4% and is now trading at $129.47. View the best growth stocks for 2023 here. Are investors shorting iShares Biotechnology ETF? iShares Biotechnology ETF saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 9,370,000 shares, a decrease of 6.4% from the April 30th total of 10,010,000 shares. Based on an average daily volume of 1,574,100 shares, the days-to-cover ratio is currently 6.0 days. View iShares Biotechnology ETF's Short Interest. How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF? iShares Biotechnology ETF announced a quarterly dividend on Monday, December 12th. Shareholders of record on Wednesday, December 14th will be paid a dividend of $0.101 per share on Monday, December 19th. This represents a $0.40 annualized dividend and a yield of 0.31%. The ex-dividend date is Tuesday, December 13th. This is a positive change from the stock's previous quarterly dividend of $0.03. Read our dividend analysis for IBB. What does IBB invest in? iShares Biotechnology ETF is a equity fund issued by iShares. IBB focuses on health care investments and follows the ICE Biotechnology Index (TR) (USD). The fund's investments total to approximately $7.57 billion assets under management. What stocks does iShares Biotechnology ETF hold? IBB invests in 275 holdings. Some of the stocks in their portfolio include Amgen (AMGN), Amgen (AMGN), Gilead Sciences (GILD), Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Vertex Pharmaceuticals (VRTX), Moderna (MRNA) and Moderna (MRNA). What is the management fee for iShares Biotechnology ETF? iShares Biotechnology ETF's management fee is 0.44% and has no other recorded expenses or fee waivers. The net expense ratio for IBB is 0.44%. When did iShares Biotechnology ETF's stock split? iShares Biotechnology ETF shares split before market open on Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were payable to shareholders after the market closes on Thursday, November 30th 2017. An investor that had 100 shares of stock prior to the split would have 300 shares after the split. What other stocks do shareholders of iShares Biotechnology ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL). What is iShares Biotechnology ETF's stock symbol? iShares Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB." Who are iShares Biotechnology ETF's major shareholders? iShares Biotechnology ETF's stock is owned by a variety of institutional and retail investors. Top institutional investors include Citigroup Inc. (3.32%), JPMorgan Chase & Co. (3.26%), Healthcare of Ontario Pension Plan Trust Fund (1.63%), Commerce Bank (1.21%), Proficio Capital Partners LLC (1.10%) and LPL Financial LLC (1.04%). How do I buy shares of iShares Biotechnology ETF? Shares of IBB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is iShares Biotechnology ETF's stock price today? One share of IBB stock can currently be purchased for approximately $129.47. How much money does iShares Biotechnology ETF make? iShares Biotechnology ETF (NASDAQ:IBB) has a market capitalization of $7.70 billion. This page (NASDAQ:IBB) was last updated on 6/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.